$72.62-0.31 (-0.43%)
Ashland Inc.
Ashland Inc. in the Basic Materials sector is trading at $72.62 with a market capitalization of $3.3B. Wall Street consensus targets $80.18 (11 analysts), implying a +10.4% move over the next 12 months. The stock is currently near its 52-week high of $78.25, remaining 19.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $497.00Mβ | $482.00Mβ | $386.00Mβ | $477.00Mβ | $463.00M |
| Gross Profit | $170.00Mβ | $147.00Mβ | $105.00Mβ | $159.00Mβ | $132.00M |
| Operating Income | $41.00Mβ | $39.00Mβ | -$9.00Mβ | $54.00Mβ | -$2.00M |
| Net Income | $16.00M | $16.00Mβ | -$12.00Mβ | $32.00Mβ | -$742.00M |
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences ...

International Flavors (IFF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.

Omega Healthcare, Clorox and Ashland have each raised dividends and offer growth catalysts, making them worth a look for investors seeking both income and total return potential.

Avient's Q2 earnings rise 20% as organic sales growth and margin expansion fuel a beat, prompting higher 2026 earnings and EBITDA guidance.